Injectable semaglutide at equivalent therapeutic doses (2.4mg weekly Wegovy) produces average weight loss of 14.9% over 68 weeks in clinical trials
Activation works with your unique biology to gradually increase GLP-1, balance hunger hormones, and strengthen the mind-body connection
When weight loss is combined with targeted pain management, physical therapy, and anti-inflammatory nutrition, many patients experience better mobility, improved function, and a higher quality of life
Suleyman, G
This condition leads to a multitude of symptoms including bloating, gas, abdominal discomfort, excessive flatulence, and malnutrition [2]
When to Seek a Personalized Program If you are struggling with weight management and are concerned about the technical side of medications, a supervised program is essential